Nasal polyps registry for long-term tracking
Part of Ear, nose & throat, Lungs & breathing clinical trials.
This study collects information from people with chronic rhinosinusitis and nasal polyps in both nostrils. By tracking patients over time, researchers hope to learn more about the condition and how to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years old or older.
- You must have a confirmed diagnosis of chronic rhinosinusitis with nasal polyps in both nostrils.
- Your polyps must be moderate or larger in size, with a score of at least 4 out of 8.
- You must have had noticeable nasal blockage or a reduced sense of smell during the past 2 weeks.
- You must be willing to commit to long-term follow-up visits and assessments.
- You cannot be pregnant or breastfeeding, and you must not have certain other serious medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an injection called LP-003 that may help reduce nasal polyps and improve breathing. It's for people whose symptoms are not controlled by standard treatments like steroid sprays or surgery.
This study is testing whether certain markers in your blood can predict how well biologic injections (medicines that reduce inflammation) will work for chronic sinusitis with nasal polyps. You'll continue your regular nasal spray and may receive a biologic or a placebo (a shot with no medicine) to see if it improves your symptoms.
This study looks for certain markers in your blood and nasal tissue that may be linked to chronic sinusitis with nasal polyps. It may help doctors understand the condition better and could lead to more targeted treatments in the future.
This study looks at how bacteria in the nose relate to a type of chronic sinusitis with nasal polyps. It may help find better treatments for this condition.
This study looks at how thick or thin your nasal fluids are and checks for certain allergy/immune cells in your nose during surgery. It helps doctors understand the type of inflammation you have, which may guide better treatments.
This study follows people with chronic rhinosinusitis and nasal polyps who are starting a biologic medication (omalizumab, mepolizumab, or dupilumab) to see how well it works in real life.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.